In this issue:
Post-ACS escitalopram improves long-term cardiac outcomes
Use of nontraditional risk factors for assessing CHD risk
A wearable ECG patch for detecting AF
Aldosterone antagonists in patients with STEMI without heart failure
Outcomes in Indigenous Australians after CABG
Five-year outcomes after fractional flow reserve-guided PCI
Sudden death in patients with CHD without severe systolic dysfunction
Plasma lipoprotein(a) levels and CHD risk
Acute kidney injury risk in Asians taking NOACs
Optimal duration of dual antiplatelet therapy after PCI
Please login below to download this issue (PDF)